Futura Medical (CE) Stock Quote FAMDF - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.41

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

0.15 52 Week Range 0.88

Market Cap

123.594M

Previous Close

0.41

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

22,576

Shares Outstanding

301,449,541

Dividend Yield

PE Ratio

-16.64

Earnings Per Share (EPS)

-0.02

Revenue

3.1M

Net Profit

-6.51M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Diversified

Website

www.futuramedical.com

Headquarters

Surrey, Gbr

Founded

2001

Futura Medical PLC (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker FAMDF. The last closing price for Futura Medical (CE) was $0.41. Over the last year, Futura Medical (CE) shares have traded in a share price range of $ 0.15 to $ 0.88.

Futura Medical (CE) currently has 301,449,541 shares outstanding. The market capitalization of Futura Medical (CE) is $123.59 million. Futura Medical (CE) has a price to earnings ratio (PE ratio) of -16.64.

Optigenex Inc. Announces Supply And License Agreement With Suracell Inc. To Utilize The AC-11(R) Trademark And Technology For Or

Company plans to market dietary supplements under the brand name Suracell with AC-11(R) (Financial terms were not disclosed). NEW YORK, Oct. 21 /PRNewswire-FirstCall/ -- Optigenex Inc...

Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan

Company extends the term and expands territorial rights of its exclusive licensee in Japan after Itochu reaches market penetration milestone of 100 customer manufacturers in Japan for...

Optigenex Inc. Enters Into Exclusive Supply and Trademark Agreements and Grants Sub-Licensing Rights to RFI, LLC of Blauvelt, Ne

RFI grants exclusive sublicense to GeneWize Life Sciences, a wholly owned subsidiary of GeneLink, Inc. to market AC-11(R) in the Affiliate Direct Selling Channel NEW YORK, Aug. 11...

Solgar Vitamin and Herb Enters Into Exclusive Trademark Licensing Agreement with Optigenex Inc. to Brand, Market and Distribute

Solgar Vitamin and Herb, global manufacturer of dietary supplements, exclusively Selects AC-11(R) for Launch in North America, Great Britain, South Africa and New Zealand. Financial Terms were not...

Itochu Corporation, Tokyo Enters Into Exclusive Supply and Trademark Licensing Agreement with Optigenex Inc. to Distribute AC-11

Twenty Fourth largest company in the world is granted exclusive licensing and sub-licensing rights to utilize the trademark AC-11(R) along with the scientific and clinical data associated with the...

RFI Ingredients Enters into Exclusive Trademark Licensing Agreement with Optigenex Inc. to Market and Distribute AC-11(R) to Hea

Life Sciences Company Selects AC-11(R) DNA Repair for Launch in Practitioner Channel NEW YORK, April 4 /PRNewswire-FirstCall/ -- Optigenex, Inc. (OTC:OPGX) (BULLETIN BOARD: OPGX) announced...

Life Extension Enters Into Trademark Agreement with Optigenex Inc. to Market and Distribute AC-11(R) in a Stand Alone Nutritiona

Major Nutritional Supplement Formulator, Marketer and Distributor Selects AC-11(R) Over Other Extracts Based on its Superior Research Profile NEW YORK, Jan. 26 /PRNewswire-FirstCall/...

LifeSpan International Inc. Enters Into Agreement With Optigenex Inc. to Market and Distribute Proprietary Skin Care Products an

Network Marketing Company Selects AC-11(R) as Core Ingredient of Product Offerings NEW YORK, Oct. 24 /PRNewswire-FirstCall/ -- Optigenex Inc. (OTC:OPGX) (BULLETIN BOARD: OPGX) announced today...

McGovern Capital LLC Enters Into Exclusive License with Optigenex Inc. for Use of AC-11(R) in Beverages

NEW YORK, Oct. 4 /PRNewswire-FirstCall/ -- Optigenex Inc. announced today the grant of an exclusive worldwide license of its patented compound AC-11(R), for the commercial use as an ingredient...

/C O R R E C T I O N -- Optigenex Inc./

In the news release, Optigenex Secures $4 Million Financing Package, issued Sept. 7, by Optigenex Inc. (OTC Bulletin Board: OPGX) over PR Newswire, we are advised by the company that the second...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.025	-5.74712643678	0.435	0.435	0.39	10819	0.40404391	CS
4	-0.05	-10.8695652174	0.46	0.58	0.39	13770	0.44211123	CS
12	-0.14	-25.4545454545	0.55	0.6	0.33	22576	0.49093288	CS
26	0.08	24.2424242424	0.33	0.6	0.33	20246	0.49674476	CS
52	-0.33	-44.5945945946	0.74	0.88	0.15	24555	0.49727826	CS
156	-0.14	-25.4545454545	0.55	2.7	0.0121	31941	0.61602278	CS
260	-0.14	-25.4545454545	0.55	2.7	0.0121	26557	0.59942001	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GRLFGreen Leaf Innovations Inc (PK)	$ 0.0002 (19,900.00%)	476k
PPJEPPJ Healthcare Enterprises Inc (PK)	$ 0.0001 (9,900.00%)	735.8k
GBCHFMetaverse Capital Corporation (CE)	$ 0.0001 (9,900.00%)	200
HCMCHealthier Choices Management Corporation (PK)	$ 0.00005 (4,900.00%)	8.04M
SPOISPO Networks Inc (CE)	$ 0.0032 (1,500.00%)	325
UTRSMinerva Surgical Inc (CE)	$ 0.000001 (-99.99%)	240
QTXBQuantRx Biomedical Corporation (CE)	$ 0.000005 (-99.88%)	2.8k
WANSFCirata PLC (PK)	$ 0.0037 (-99.26%)	3k
AUVIQApplied UV Inc (CE)	$ 0.0001 (-99.23%)	10.21k
GTEHGenTech Holdings Inc (CE)	$ 0.000001 (-99.00%)	500k
GMPRGourmet Provisions International Corporation (PK)	$ 0.0002 (100.00%)	235.11M
ASIIAccredited Solutions Inc (PK)	$ 0.00025 (25.00%)	145.73M
AHROAuthentic Holdings Inc (CE)	$ 0.0014 (100.00%)	73.21M
WDLFDecentral Life Inc (PK)	$ 0.0004 (-11.11%)	61.5M
HMBLHUMBL Inc (PK)	$ 0.00015 (-25.00%)	49M